Drug Shortage Report for RAN-CITALO
Report ID | 52425 |
Drug Identification Number | 02285630 |
Brand name | RAN-CITALO |
Common or Proper name | CITALOPRAM |
Company Name | RANBAXY PHARMACEUTICALS CANADA INC. |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | CITALOPRAM |
Strength(s) | 40MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | N06AB |
ATC description | ANTIDEPRESSANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2018-11-23 |
Actual start date | 2018-11-28 |
Estimated end date | Unknown |
Actual end date | 2018-12-03 |
Shortage status | Resolved |
Updated date | 2019-02-04 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 126 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2018-06-14 | English | Compare |
v2 | 2018-06-14 | French | Compare |
v3 | 2018-06-15 | English | Compare |
v4 | 2018-07-25 | English | Compare |
v5 | 2018-07-25 | French | Compare |
v6 | 2018-08-21 | English | Compare |
v7 | 2018-08-21 | French | Compare |
v8 | 2018-08-21 | English | Compare |
v9 | 2018-11-28 | English | Compare |
v10 | 2018-11-28 | French | Compare |
v11 | 2018-11-29 | English | Compare |
v12 | 2019-02-04 | English | Compare |
v13 | 2019-02-04 | French | Compare |
Showing 1 to 13 of 13